The Gairdner Awards are Canada’s most prestigious awards in biomedical research, recognising scientific excellence and international impact on human health. Of the 395 Gairdner recipients, nearly a quarter have gone on to win a Nobel Prize, and many are actively involved in COVID-related research.
So if you have questions about the pandemic, these are the people to ask. Luckily, you have an opportunity to do just that.
This Wednesday, May 20, join the Gairdner Foundation for COVID-19: The Road Forward – Gairdner Global Perspectives Panel. From 11 am to 1 pm EST the panel of Gairdner laureates and pre-eminent scientists will discuss COVID-19 and answer questions about the pandemic and what happens next.
These world-renowned experts in virology, vaccines and global health will explore the science of coronavirus infections, the urgent search for drug therapies and vaccines, how to model outbreaks and the impact of the pandemic on vulnerable populations worldwide.
Register to join the panel as they share their unique insights into the COVID-19 pandemic and their hopes for the future.
Quarraisha and Salim Abdool Karim
2020 John Dirks Canada Gairdner Global Health Awards
Founding leaders of the Centre for the AIDS Program of Research, South Africa
Together, Quarraisha and Salim discovered that antiretrovirals prevent sexual transmission of HIV, laying the foundations for pre-exposure prophylaxis (PrEP) and contributing to the reduction of HIV infection in Africa and around the world.
Chair Emeritus, Gairdner Foundation
Founding Director, Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta
A leading figure in Canadian health research and in understanding and addressing viral disease, in particular hepatitis B and C.
2018 John Dirks Canada Gairdner Global Health Award
Director of the Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
With longtime collaborator Alan Lopez, Murrary conceptualized and quantified the ‘Global Burden of Disease’, part of an extensive career in understanding and interpreting the data of health worldwide.
2017 Canada Gairdner International Award
Chief Scientist and Head External R&D, GSK Vaccines in Siena, Italy
Dr. Rappuoli is a leader in vaccine innovation and Gairdner laureate for using reverse vaccinology, a genomic approach to vaccine discovery, that resulted in a life-saving meningococcus B vaccine.
COVID-19: The Road Forward – Gairdner Global Perspectives Panel
Wednesday, May 20, 2020
11:00 am – 1:00 pm EST